NCT02910817View on ClinicalTrials.gov

Impact of Metformin on In Vitro Fertilization Outcomes in Overweight and Obese PCOS Women

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin

The metformin-treated group received metformin (1000 mg per day) with the start of controlled ovarian stimulation (COH) until the day of the pregnancy check.

OTHER

Placebo

Placebo

Trial Locations (1)

71515

Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02910817 - Impact of Metformin on In Vitro Fertilization Outcomes in Overweight and Obese PCOS Women | Biotech Hunter | Biotech Hunter